US Stock MarketDetailed Quotes

Liminatus Pharma (LIMN)

Watchlist
  • 0.1850
  • -0.0065-3.39%
Close May 13 16:00 ET
  • 0.1880
  • +0.0030+1.62%
Post 20:01 ET
8.30MMarket Cap-0.49P/E (TTM)

Liminatus Pharma (LIMN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.88%2.97M
429.22%884.21K
29.09%701.17K
22.99%1.12M
3.24%255
-30.90%3.33M
-78.07%167.08K
543.15K
909.22K
-99.99%247
Selling and administrative expenses
360.40%2.97M
429.22%884.21K
276.81%701.17K
473.19%1.12M
----
-39.30%644.62K
255.48%167.08K
--186.08K
--195.08K
-71.76%96K
-General and administrative expense
360.40%2.97M
429.22%884.21K
276.81%701.17K
473.19%1.12M
----
-39.30%644.62K
255.48%167.08K
--186.08K
--195.08K
-71.76%96K
Research and development costs
--0
--0
--0
--0
----
-28.52%2.69M
--0
--357.07K
--714.13K
0.00%1.61M
Other taxes
----
----
----
----
3.24%255
----
----
----
----
--247
Operating profit
10.88%-2.97M
-429.22%-884.21K
-29.09%-701.17K
-22.99%-1.12M
-3.24%-255
30.90%-3.33M
78.07%-167.08K
-543.15K
-909.22K
99.99%-247
Net non-operating interest income expense
35.61%-139.31K
69.60%-19.05K
67.28%-19.05K
27.09%-37.91K
-31.12%-216.36K
-596.39%-62.68K
-58.23K
-51.99K
22.81%-44K
Non-operating interest income
-37.49%76.59K
--0
--0
-3.36%24.38K
----
1,125.26%122.53K
443.61%43.49K
--34.48K
--25.23K
--19K
Non-operating interest expense
-36.29%215.9K
-82.06%19.05K
-79.45%19.05K
-19.34%62.29K
----
93.65%338.88K
524.49%106.16K
--92.71K
--77.22K
10.53%63K
Other net income (expense)
-7.1M
-7.27M
-1.1M
1.27M
Gain on sale of security
--54.31K
--94.34K
--76.87K
---116.89K
----
----
----
----
----
----
Special income (charges)
--402.3K
--0
---1.74M
--2.14M
----
--0
--0
--0
--0
----
-Less:Other special charges
---402.3K
--0
--1.74M
---2.14M
----
----
----
----
----
----
Other non- operating income (expenses)
---7.56M
---7.36M
--560K
---756K
----
----
----
----
----
----
Income before tax
-187.81%-10.21M
-3,455.54%-8.17M
-203.20%-1.82M
111.79%113.29K
-3.24%-255
28.85%-3.55M
70.20%-229.75K
-601.37K
-961.21K
99.99%-247
Income tax
Net income
-187.81%-10.21M
-3,455.54%-8.17M
-203.20%-1.82M
111.79%113.29K
-3.24%-255
28.85%-3.55M
70.20%-229.75K
-601.37K
-961.21K
99.99%-247
Net income continuous Operations
-187.81%-10.21M
-3,455.54%-8.17M
-203.20%-1.82M
111.79%113.29K
-3.24%-255
28.85%-3.55M
70.20%-229.75K
---601.37K
---961.21K
99.99%-247
Minority interest income
Net income attributable to the parent company
-187.81%-10.21M
-3,455.54%-8.17M
-203.20%-1.82M
111.79%113.29K
-3.24%-255
28.85%-3.55M
70.20%-229.75K
-601.37K
-961.21K
99.99%-247
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-187.81%-10.21M
-3,455.54%-8.17M
-203.20%-1.82M
111.79%113.29K
-3.24%-255
28.85%-3.55M
70.20%-229.75K
-601.37K
-961.21K
99.99%-247
Basic earnings per share
-215.43%-0.43
-3,749.64%-0.34
-202.81%-0.07
0
-11.11%-0
28.85%-0.1363
70.20%-0.0088
-0.0231
-0.0369
99.99%-0
Diluted earnings per share
-215.43%-0.43
-3,749.64%-0.34
-202.81%-0.07
0
-11.11%-0
28.85%-0.1363
70.20%-0.0088
-0.0231
-0.0369
99.99%-0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.88%2.97M429.22%884.21K29.09%701.17K22.99%1.12M3.24%255-30.90%3.33M-78.07%167.08K543.15K909.22K-99.99%247
Selling and administrative expenses 360.40%2.97M429.22%884.21K276.81%701.17K473.19%1.12M-----39.30%644.62K255.48%167.08K--186.08K--195.08K-71.76%96K
-General and administrative expense 360.40%2.97M429.22%884.21K276.81%701.17K473.19%1.12M-----39.30%644.62K255.48%167.08K--186.08K--195.08K-71.76%96K
Research and development costs --0--0--0--0-----28.52%2.69M--0--357.07K--714.13K0.00%1.61M
Other taxes ----------------3.24%255------------------247
Operating profit 10.88%-2.97M-429.22%-884.21K-29.09%-701.17K-22.99%-1.12M-3.24%-25530.90%-3.33M78.07%-167.08K-543.15K-909.22K99.99%-247
Net non-operating interest income expense 35.61%-139.31K69.60%-19.05K67.28%-19.05K27.09%-37.91K-31.12%-216.36K-596.39%-62.68K-58.23K-51.99K22.81%-44K
Non-operating interest income -37.49%76.59K--0--0-3.36%24.38K----1,125.26%122.53K443.61%43.49K--34.48K--25.23K--19K
Non-operating interest expense -36.29%215.9K-82.06%19.05K-79.45%19.05K-19.34%62.29K----93.65%338.88K524.49%106.16K--92.71K--77.22K10.53%63K
Other net income (expense) -7.1M-7.27M-1.1M1.27M
Gain on sale of security --54.31K--94.34K--76.87K---116.89K------------------------
Special income (charges) --402.3K--0---1.74M--2.14M------0--0--0--0----
-Less:Other special charges ---402.3K--0--1.74M---2.14M------------------------
Other non- operating income (expenses) ---7.56M---7.36M--560K---756K------------------------
Income before tax -187.81%-10.21M-3,455.54%-8.17M-203.20%-1.82M111.79%113.29K-3.24%-25528.85%-3.55M70.20%-229.75K-601.37K-961.21K99.99%-247
Income tax
Net income -187.81%-10.21M-3,455.54%-8.17M-203.20%-1.82M111.79%113.29K-3.24%-25528.85%-3.55M70.20%-229.75K-601.37K-961.21K99.99%-247
Net income continuous Operations -187.81%-10.21M-3,455.54%-8.17M-203.20%-1.82M111.79%113.29K-3.24%-25528.85%-3.55M70.20%-229.75K---601.37K---961.21K99.99%-247
Minority interest income
Net income attributable to the parent company -187.81%-10.21M-3,455.54%-8.17M-203.20%-1.82M111.79%113.29K-3.24%-25528.85%-3.55M70.20%-229.75K-601.37K-961.21K99.99%-247
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -187.81%-10.21M-3,455.54%-8.17M-203.20%-1.82M111.79%113.29K-3.24%-25528.85%-3.55M70.20%-229.75K-601.37K-961.21K99.99%-247
Basic earnings per share -215.43%-0.43-3,749.64%-0.34-202.81%-0.070-11.11%-028.85%-0.136370.20%-0.0088-0.0231-0.036999.99%-0
Diluted earnings per share -215.43%-0.43-3,749.64%-0.34-202.81%-0.070-11.11%-028.85%-0.136370.20%-0.0088-0.0231-0.036999.99%-0
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More